Dengue cases at an all-time high in Americas Region: PAHO report
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,
Health
Medical
Pharma
Drugs
Health
Pharma
GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season
Drugs
Health
Pharma
Sage Therapeutics halts trials of experimental drug to treat dementia
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered
Climate
Health
Pharma
Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers
Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to
Climate
Health
Medical
Human life expectancy has hit its upper limits, says US research
HQ Team October 8, 2024:Humanity is hitting the upper limit of life expectancy, according to a new study. Medical advances have led to
Drugs
Health
Medical
J&J stops trials on drug to treat muscle-invasive bladder cancer
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
Drugs
Health
Medical
Balancing gut bacteria can reduce inflammation in rheumatoid arthritis
HQ Team October 7, 2024: Rheumatoid arthritis (RA), an autoimmune disease that causes joint and bone inflammation, is affected by gut bacteria. Researchers
Drugs
Health
Medical
UK’s DIOSynVax develops single candidate vaccine for bird flu virus
UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza
Drugs
Health
Pharma
US drug regulator clears Qnovia’s nicotine inhaler for clinical testing
HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US
Drugs
Health
Medical
AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic